Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Ra Capital Management, L.P. reported a 9.90% stake in Mineralys Therapeutics, Inc. (Schedule 13D/A)

Event Sep 4, 2025 · Filed Sep 8, 2025

Ra Capital Management, L.P. reported a 9.90% stake in Mineralys Therapeutics, Inc., 7,796,433 shares, with active intent on Sep 4, 2025. Filed Sep 8, 2025 (Schedule 13D/A).

Stake
9.90%
Shares
7,796,433
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%7,796,433
Peter Kolchinsky9.90%7,796,433
Rajeev Shah9.90%7,796,433
RA Capital Healthcare Fund, L.P.7.50%5,846,161

Source

View original at SEC

Related